[[1-(2-Benzofuran-3-yl-acetyl)-2-methyl-azetidine-2-carbonyl]-(4-chloro-benzyl)-amino]-acetic acid

ID: ALA3706689

PubChem CID: 89894269

Max Phase: Preclinical

Molecular Formula: C24H23ClN2O5

Molecular Weight: 454.91

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C(=O)N(CC(=O)O)Cc2ccc(Cl)cc2)CCN1C(=O)Cc1coc2ccccc12

Standard InChI:  InChI=1S/C24H23ClN2O5/c1-24(23(31)26(14-22(29)30)13-16-6-8-18(25)9-7-16)10-11-27(24)21(28)12-17-15-32-20-5-3-2-4-19(17)20/h2-9,15H,10-14H2,1H3,(H,29,30)

Standard InChI Key:  IQRXHRLXJWKWSZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   14.1694   -3.5817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9806   -3.7320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2560   -4.5097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7202   -5.1370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9956   -5.9147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8068   -6.0651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0822   -6.8427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5464   -7.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7352   -7.3197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4598   -6.5420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8218   -8.2477    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   16.0672   -4.6600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3426   -5.4377    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.3381   -4.4072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6030   -4.0327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9775   -3.2976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7126   -3.6722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8008   -3.8401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5930   -5.1919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0410   -5.8050    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4000   -5.3634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1700   -6.8155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6549   -7.4829    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4395   -7.2280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4395   -6.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6549   -6.1480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1540   -5.9905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8685   -6.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8685   -7.2280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1540   -7.6405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8941   -2.8040    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6336   -4.2090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  5 10  2  0
  8 11  1  0
  3  4  1  0
 12 13  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 14 17  1  0
 12 15  1  0
 15 18  1  0
 19 20  2  0
 19 21  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 22 26  2  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 24 30  1  0
 25 27  1  0
 21 26  1  0
 14 19  1  0
  3 12  1  0
  2  3  1  0
  1 31  1  0
  1 32  2  0
M  END

Associated Targets(Human)

FFAR2 Tchem Free fatty acid receptor 2 (545 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.91Molecular Weight (Monoisotopic): 454.1295AlogP: 3.73#Rotatable Bonds: 7
Polar Surface Area: 91.06Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.73CX Basic pKa: CX LogP: 2.87CX LogD: -0.43
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.59Np Likeness Score: -0.64

References

1. Pizzonero M, Dupont S, Babel M, Beaumont S, Bienvenu N, Blanqué R, Cherel L, Christophe T, Crescenzi B, De Lemos E, Delerive P, Deprez P, De Vos S, Djata F, Fletcher S, Kopiejewski S, L'Ebraly C, Lefrançois JM, Lavazais S, Manioc M, Nelles L, Oste L, Polancec D, Quénéhen V, Soulas F, Triballeau N, van der Aar EM, Vandeghinste N, Wakselman E, Brys R, Saniere L..  (2014)  Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic.,  57  (23): [PMID:25380412] [10.1021/jm5012885]

Source